Startup will bring gene sequencing to cancer care

10/18/2011 | Forbes

Health care venture capitalist Brook Byers is partnering with Google Ventures in a Series A financing round worth $33.5 million to help establish Foundation Medicine. The startup will help physicians choose the right drug for cancer treatment using gene-sequencing technology. Novartis and Celgene are on board to use Foundation's test in trials. Marketing of the test, worth $3,500 to $4,500, to oncologists and pathologists could come next year.

View Full Article in:

Forbes

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Chief Quality Officer
UnityPoint Clinic
Des Moines, ID
Director, Payer Marketing
Avalere Health
Washington, DC
The Pew Charitable Trusts
Director, Antibiotics and Innovation Project
Washington, DC
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX